Clarithromycin and pulmonary infiltration with eosinophilia.
Terzano
Claudio
C
Respiratory Diseases Unit, Department of Cardiovascular and Respiratory Sciences, University of Rome (La Sapienza), Rome, Italy. cterzano@tin.it
Petroianni
Angelo
A
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001249:Asthma / Q000150:complications*; D002248:Carbon Monoxide; D002559:Cerebrospinal Fluid Rhinorrhea / Q000150:complications / Q000188:drug therapy; D017291:Clarithromycin / Q000009:adverse effects*; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D008297:Male; D011657:Pulmonary Eosinophilia / Q000139:chemically induced* / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D002248:Carbon Monoxide; D017291:Clarithromycin